TW202602460A - 用於消除耳念珠菌移生之抗真菌劑 - Google Patents

用於消除耳念珠菌移生之抗真菌劑

Info

Publication number
TW202602460A
TW202602460A TW114112703A TW114112703A TW202602460A TW 202602460 A TW202602460 A TW 202602460A TW 114112703 A TW114112703 A TW 114112703A TW 114112703 A TW114112703 A TW 114112703A TW 202602460 A TW202602460 A TW 202602460A
Authority
TW
Taiwan
Prior art keywords
compound
formula
candida auris
pharmaceutically acceptable
individual
Prior art date
Application number
TW114112703A
Other languages
English (en)
Chinese (zh)
Inventor
岡札萊茲 大衛 A 安古洛
斯蒂芬 安德魯 巴拉特
Original Assignee
美商塞納西斯公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商塞納西斯公司 filed Critical 美商塞納西斯公司
Publication of TW202602460A publication Critical patent/TW202602460A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
TW114112703A 2019-05-16 2020-05-15 用於消除耳念珠菌移生之抗真菌劑 TW202602460A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962849019P 2019-05-16 2019-05-16
US62/849,019 2019-05-16
PCT/US2020/032547 WO2020232037A1 (en) 2019-05-16 2020-05-12 Antifungal agents, like ibrexafungerp for candida auris decolonization
WOPCT/US2020/032547 2020-05-12

Publications (1)

Publication Number Publication Date
TW202602460A true TW202602460A (zh) 2026-01-16

Family

ID=70861571

Family Applications (2)

Application Number Title Priority Date Filing Date
TW114112703A TW202602460A (zh) 2019-05-16 2020-05-15 用於消除耳念珠菌移生之抗真菌劑
TW109116151A TWI881977B (zh) 2019-05-16 2020-05-15 用於消除耳念珠菌移生之抗真菌劑

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW109116151A TWI881977B (zh) 2019-05-16 2020-05-15 用於消除耳念珠菌移生之抗真菌劑

Country Status (14)

Country Link
US (1) US20220211684A1 (cg-RX-API-DMAC7.html)
EP (1) EP3968986A1 (cg-RX-API-DMAC7.html)
JP (2) JP7770191B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220009416A (cg-RX-API-DMAC7.html)
CN (1) CN113905733A (cg-RX-API-DMAC7.html)
AU (1) AU2020276595B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021022876A2 (cg-RX-API-DMAC7.html)
CA (1) CA3140637A1 (cg-RX-API-DMAC7.html)
EA (1) EA202193146A1 (cg-RX-API-DMAC7.html)
IL (1) IL288165B2 (cg-RX-API-DMAC7.html)
MA (1) MA55958A (cg-RX-API-DMAC7.html)
MX (1) MX2021013899A (cg-RX-API-DMAC7.html)
TW (2) TW202602460A (cg-RX-API-DMAC7.html)
WO (1) WO2020232037A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102980640B1 (ko) 2023-07-03 2026-06-24 연세대학교 산학협력단 칸디다 아우리스에 대한 항진균제 스크리닝 방법 및 항진균용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
ES2402659T3 (es) 2006-04-03 2013-05-07 Merck Sharp & Dohme Corp. Derivados de enfumafungina como agentes antifúngicos
WO2010019204A1 (en) 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
BRPI0912074B1 (pt) * 2008-08-12 2021-08-03 Merck Sharp & Dohme Corp Composto e composição farmacêutica
ES2955711T3 (es) * 2016-03-16 2023-12-05 Cidara Therapeutics Inc Regímenes de dosificación para el tratamiento de infecciones fúngicas
JP7263313B2 (ja) * 2017-04-10 2023-04-24 サイネクシス,インコーポレーテッド 併用される抗真菌剤
WO2018213641A1 (en) * 2017-05-17 2018-11-22 T2 Biosystems, Inc. Nmr methods and systems for the rapid detection of candida species
PL3661503T3 (pl) * 2017-08-04 2023-01-09 Scynexis, Inc. Środki przeciwgrzybicze o zwiększonej aktywności przy kwasowym odczynie ph
MA54866A (fr) * 2019-01-30 2022-05-04 Scynexis Inc Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques

Also Published As

Publication number Publication date
MX2021013899A (es) 2022-02-10
IL288165B1 (en) 2026-01-01
JP7770191B2 (ja) 2025-11-14
EA202193146A1 (ru) 2022-02-11
BR112021022876A2 (pt) 2022-04-12
TWI881977B (zh) 2025-05-01
IL288165A (en) 2022-01-01
WO2020232037A1 (en) 2020-11-19
JP2022532734A (ja) 2022-07-19
CN113905733A (zh) 2022-01-07
MA55958A (fr) 2022-03-23
IL288165B2 (en) 2026-05-01
AU2020276595B2 (en) 2025-12-04
JP2025118765A (ja) 2025-08-13
TW202110441A (zh) 2021-03-16
CA3140637A1 (en) 2020-11-19
AU2020276595A1 (en) 2021-12-09
US20220211684A1 (en) 2022-07-07
EP3968986A1 (en) 2022-03-23
KR20220009416A (ko) 2022-01-24

Similar Documents

Publication Publication Date Title
RU2560676C2 (ru) Противотуберкулезная композиция, содержащая соединения оксазола
JPWO2012060448A1 (ja) 抗真菌剤としての併用医薬組成物
US20050014706A1 (en) Method of treating tuberculosis
AU2024227501A1 (en) Antifungal agents with enhanced activity in acidic pH
TW201002322A (en) Treatment of antibiotic-resistant bacteria infection
JP2025118765A (ja) カンジダ・アウリス(Candida auris)脱コロニー化のためのイブレクサファンゲルプのような抗真菌剤
CN101301289B (zh) 小檗碱及其结构类似物在逆转多药耐药泵中的应用
JP6842088B2 (ja) 抗真菌活性を有する組成物
CN113332277B (zh) 一种吡咯二酮化合物在制备抗真菌药物中的应用
HK40067174A (en) Antifungal agents, like ibrexafungerp for candida auris decolonization
EA048874B1 (ru) Противогрибковые агенты для деколонизации candida auris
CN113498343A (zh) 用于治疗真菌性骨关节感染的三萜抗真菌剂
CN113456641B (zh) 一种化合物在制备抗真菌药物中的应用
JP5105818B2 (ja) 医薬組成物
CN113318107B (zh) 一种含氮化合物在制备抗真菌药物中的应用
CN118806911B (zh) Fosmanogepix在堪萨斯分枝杆菌感染中的应用
TW202541815A (zh) 用於治療黴菌感染之三萜類抗真菌劑
KR101893005B1 (ko) 신규한 루파리엘롤라이드의 피리다진온 유도체 화합물 및 이를 유효성분으로 포함하는 항균용 조성물
JP2022523212A (ja) ニューモシスチス属種(Pneumocystis spp.)肺炎を治療又は予防するためのトリテルペノイド系抗真菌薬
US7618986B2 (en) Method of treating latent tuberculosis
WO2020209215A1 (ja) 抗真菌剤
HK40022879B (en) Antifungal agents used in combination